NHC

Healthcare Stock NHC Takes Center Stage

National Healthcare Corporation (NYSE American: NHC) has declared a quarterly dividend of 59 cents per common share, payable on May 1, 2024, to shareholders of record on March 29, 2024. The nation's oldest publicly traded long-term health care company made this announcement on February 9, 2024.

Following the announcement, the company's shares experienced a 1.5% increase and are currently trading at a price of $92.35.

In a statement, Brian F. Kidd, Senior Vice President and Chief Financial Officer, remarked, "We are pleased to continue our long-standing tradition of rewarding our shareholders through the declaration of this dividend."

The company's full 8-K submission is available here.

2018 2019 2020 2021 2022 2023
Revenue (MM) $980 $996 $1,028 $1,074 $1,086 $1,105
Revenue Growth n/a 1.64% 3.19% 4.48% 1.06% 1.79%
Operating Margins 6% 5% 5% 5% 3% 4%
Net Margins 6% 7% 4% 13% 2% 4%
Net Income (MM) $59 $68 $42 $139 $22 $45
Net Interest Expense (MM) $7 $7 $6 $5 $5 $7
Depreciation & Amort. (MM) $42 $42 $42 $41 $40 $41
Earnings Per Share $3.87 $4.44 $2.72 $8.99 $1.45 $2.91
EPS Growth n/a 14.73% -38.74% 230.51% -83.87% 100.69%
Diluted Shares (MM) 15 15 15 15 15 15
Free Cash Flow (MM) $69 $74 $181 $23 -$21 $72
Capital Expenditures (MM) $30 $26 $22 $39 $30 $25
Current Ratio 2.04 1.75 1.62 1.62 1.79 1.87
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS